KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $3.2 billion.

  • Boston Scientific's Accumulated Expenses rose 1543.45% to $3.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.2 billion, marking a year-over-year increase of 1543.45%. This contributed to the annual value of $3.2 billion for FY2025, which is 1543.45% up from last year.
  • According to the latest figures from Q4 2025, Boston Scientific's Accumulated Expenses is $3.2 billion, which was up 1543.45% from $3.0 billion recorded in Q3 2025.
  • Boston Scientific's 5-year Accumulated Expenses high stood at $3.2 billion for Q4 2025, and its period low was $1.9 billion during Q1 2023.
  • In the last 5 years, Boston Scientific's Accumulated Expenses had a median value of $2.3 billion in 2024 and averaged $2.4 billion.
  • As far as peak fluctuations go, Boston Scientific's Accumulated Expenses surged by 4214.2% in 2021, and later tumbled by 1836.23% in 2022.
  • Over the past 5 years, Boston Scientific's Accumulated Expenses (Quarter) stood at $2.4 billion in 2021, then decreased by 11.33% to $2.2 billion in 2022, then grew by 22.5% to $2.6 billion in 2023, then grew by 4.8% to $2.8 billion in 2024, then grew by 15.43% to $3.2 billion in 2025.
  • Its Accumulated Expenses stands at $3.2 billion for Q4 2025, versus $3.0 billion for Q3 2025 and $2.8 billion for Q2 2025.